Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentostatin for Refractory Chronic Graft-Versus-Host Disease
NCT00074035Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Dec 2003
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pentostatin in chronic graft-versus-host disease (cGVHD), sponsored by Cancer and Leukemia Group B. Primary endpoint: Response Rate at 3 months. Started Dec 2003; status: completed.
02
Drugs
pentostatin
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT00074035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00074035.